| NREH | normal renin essential hypertension |
|---|---|
| REH | renin essential hypertension |
| JVP | [POMD P 49 - 52] 1) Jugular Vein Pressure 2) Jugular Venous Pulse ... |
| IPH | idiopathic portal hypertension; idiopathic pulmonary hemosiderosis; idiopathic pulmonary hypertensio... |
| PHT | phenytoin; portal hypertension; primary hyperthyroidism; pulmonary hypertension |
| essential gene | <genetics> Any gene that, if it does not workcorrectly, kills the organism. (09 Oct 1997) |
|---|---|
| essential oils | Plant products, usually somewhat volatile, giving the odours and tastes characteristic of the particular plant, thus possessing the essence, e.g., citral, pinene, camphor, menthane, terpenes; usually, the steam distillates of plants or oils of plants obtained by pressing out the rinds of a particular plant. See: volatile oil. (05 Mar 2000) |
| essential phthisis bulbi | A softening of the eyeball (ophthalmomalacia) and reduction in size, not due to inflammation. (05 Mar 2000) |
| essential progressive atrophy of iris | Progressive atrophy of the iris without inflammatory signs, characterised by patchy loss of all layers of the iris with hole formation, migration of the pupil, degeneration of the corneal endothelium, peripheral anterior synechiae, and secondary glaucoma; usually unilateral, predominantly affecting women in their middle years. (05 Mar 2000) |
| essential pruritus | Itching that occurs independently of skin lesions. (05 Mar 2000) |
| essential tachycardia | Persistent rapid action of the heart due to no discoverable organic lesion. (05 Mar 2000) |
| essential telangiectasia | Localised capillary dilation of undetermined origin. Synonym: angioma serpiginosum. (05 Mar 2000) |
| essential thrombocythaemia | A rare condition related to polycythaemia rubra vera characterised by the production of large numbers of abnormal platelets. Symptoms include haemorrhage, blood clots and enlargement of the spleen. Treatment varies according to the severity of the disease. (13 Nov 1997) |
| essential thrombocytopenia | A primary form of thrombocytopenia, in contrast to secondary forms that are associated with metastatic neoplasms, tuberculosis, and leukaemia involving the bone marrow, or with direct suppression of bone marrow by the use of chemical agents, or with other conditions. (05 Mar 2000) |
| essential tremor | <neurology> A tremor that is associated with purposeful movement or motor activity. Essential tremor is the most common form of tremor with no identifiable cause. Stress, anxiety and the use of stimulants (for example caffeine, decongestants) can often make the tremor worse. Treatment is usually not necessary for this benign condition. (27 Sep 1997) |
| fatty acids, essential | Fatty acids that cannot be synthesised by the human body and must be obtained from dietary sources, e.g., linoleic acids and linolenic acids. (12 Dec 1998) |
| accelerated hypertension | <cardiology> A severe form of acute hypertension that results in the abrupt rise in the blood pressure (diastolic pressure often over 120 mmHg). If left untreated, malignant hypertension can cause damage to the blood vessels in the eye, kidneys, brain and heart. Complications include stroke, heart attack, blindness and renal failure. Symptoms include headache, blurred vision, nausea, vomiting and lethargy. Neurologic symptoms are also a common finding. Malignant hypertension occurs more commonly in males, African Americans and those with a history for hypertension. (27 Sep 1997) |
| adrenal hypertension | Hypertension due to an adrenal medullary pheochromocytoma or to hyperactivity or functioning tumour of the adrenal cortex. (05 Mar 2000) |
| benign hypertension | Hypertension that runs a relatively long and symptomless course. (05 Mar 2000) |
| borderline hypertension | By consensus, that blood pressure zone between highest acceptable "normal" blood pressure and hypertensive blood pressure. The Framingham Heart Study defines this as pressures between 140 and 160 mm Hg systolic and 90 and 95 mm Hg diastolic. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|